Possible prognostic value of leukotriene B4 in acute respiratory distress syndrome

Respiratory Care

Volumn 52, Issue 12, 2007, Pages 1695-1700

  Masclans, Joan R ^a   Sabater, Joan ^a   Sacanell, Judit ^a   Chacon, Pilar ^a   Sabin, Pilar ^a   Roca, Oriol ^a   Planas, Mercè ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute respiratory distress syndrome; ARDS; Leukotriene B4; Outcome; Prognostic value; Prostacyclin; Thromboxane B2

Indexed keywords

ICOSANOID; LEUKOTRIENE B4; PROSTAGLANDIN F1 ALPHA; THROMBOXANE B2; DIAGNOSTIC AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG INJURY; MALE; OXYGEN TENSION; POPULATION; PROGNOSIS; PROSPECTIVE STUDY; SURVIVOR; VENOUS BLOOD; ADULT; AGED; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; SPAIN;

ADULT; AGED; FEMALE; HUMANS; LEUKOTRIENE B4; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; SPAIN;

EID: 40649103696     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 1994;20(3):225-232.
2. Matthay MA, Abraham E. Beta-adrenergic agonist therapy as a potential treatment for acute lung injury. Am J Respir Crit Care Med 2006;173(3):254-255.
3. Roca O, Sacanell J, Laborda C, Pérez M, Sabater J, Burgueño MJ, et al. Cohort study on the incidence of ARDS in patients admitted to the ICU and mortality prognostic. Med Intensiva 2006;30(1):6-12 (article in Spanish).
4. Tzouvelekis A, Pneumatikos I, Bouros D. Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res 2005;6:62.
5. Ku EC, Lee W, Kothari HV, Scholer DW. Effect of diclofenac sodium on the arachidonic acid cascade. Am J Med 1986;80(4B):18-23.
6. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989;84(5):1609-1619.
7. Antonelli M, Bufi M, De Blasi RA, Crimi G, Conti G, Mattia C, et el. Detection of leukotrienes B4, C4 and of their isomers in arterial, mixed venous plasma and bronchoalveolar lavage fluid from ARDS patients. Intensive Care Med 1989;15(5):296-301.
8. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997;336(13):912-918.
9. Ferrer M, Torres A, Baer R, Hernandez C, Roca J, Rodriguez-Roisin R. Effect of acetylsalicylic acid on pulmonary gas exchange in patients with severe pneumonia: a pilot study. Chest 1997;111(4):1094-1100.
10. Planas M, Masclans JR, Iglesia R, Porta I, Valls M, Bermejo B. Eicosanoids and fat emulsions in acute respiratory distress syndrome patients. Nutrition 1997;13(3):202-205.
11. Masclans JR, Iglesia R, Bermejo B, Pico M, Rodriguez-Roisin R, Planas M. Gas exchange and pulmonary haemodynamic responses to fat emulsions in acute respiratory distress syndrome. Intensive Care Med 1998;24(9):918-923.
12. Masclans JR, Bermejo B, Pico M, de Latorre FJ, Rodriguez-Roisin R, and Planas M. The prognostic value of eicosanoids in the acute respiratory distress syndrome. Med Clin (Barc) 1999;112(3):81-84 (article in Spanish).
13. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138(3):720-723.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13(10):818-829.
15. Lamy M, Deby-Dupont G, Deby C, Braun M, Van Erck J, Damas P. Arachidonic acid and cyclo-oxigenase metabolism in acute lung injury. In: Artigas A, Lemaire L, Suter PM, Zapol WM, editors. Acute respiratory distress syndrome. New York: Churchill Livingstone; 1992:105-119.
16. Chung KF. Platelet-activating factor in inflammation and pulmonary disorders. Clin Sci (Lond) 1992;83(2):127-138.
17. Masclans JR, Barberà JA, MacNee W, Pavia J, Piera C, Lomena F, et al. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. Am J Respir Crit Care Med 1996;154(2 Pt 1):529-532.
18. Marra SW, Oliver AM. Successful treatment of adult respiratory distress syndrome with oral ibuprofen (letter). Crit Care Med 1991;19(2):301.
19. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317(25):1565-1570.
20. Bone RC, Slotman G, Maunder R, Silverman H, Hyers TM, Kerstein MD, Ursprung JJ. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Chest 1989;96(1):114-119.
21. Russell JA, Ronco JJ, Dodek PM. Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome. Chest 1990;97(3):684-692.
22. Shoemaker WC, Appel PL. Effects of prostaglandin E1 in adult respiratory distress syndrome. Surgery 1986;99(3):275-283.
23. Amat M, Barcons M, Mancebo J, Mateo J, Oliver A, Mayoral JF, et al. Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Crit Care Med 2000;28(1):57-62.
24. Bowton DL. Leukotriene B4, acute respiratory distress syndrome, and outcomes. Crit Care Med 2000;28(1):262-263.
25. Stephenson AH, Lonigro AJ, Hyers TM, Webster RO, Fowler AA. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988;138(3):714-719.
26. Caironi P, Ichinose F, Liu R, Jones RC, Bloch KD, Zapol WM. 5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury. Am J Respir Crit Care Med 2005;172(3):334-343.
27. Effros RM, Biller J, Foss B, Hoagland K, Dunning MB, Castillo D, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003;168(12):1500-1505.
28. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986;1(8471):11-14.